FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for METOPROLOL TARTRATE by Mylan Pharmaceuticals Inc., confirming approval of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Myocardial Infarction

Drugs mentioned

• METOPROLOL TARTRATE (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL TARTRATE (METOPROLOL TARTRATE)